US FDA says trials of modified vaccines for COVID-19 variants could take months
Acting FDA Commissioner Janet Woodcock said companies should not wait until a mutated virus is demonstrated to be able to escape…
Author
Indian pharma companies say they can quickly rework vaccines to tackle COVID-19 variants
India is the world’s biggest maker of vaccines, and its companies have promised to produce billions of doses of COVID-19 shots
WHO agrees on compensation plan in case of serious side effects of COVAX vaccine
By providing a no-fault lump-sum compensation in full and final settlement of any claims, the COVAX programme aims to…
GSK, Sanofi begin new COVID-19 vaccine study after setback
The companies aim to reach final testing in the second quarter, and if the results are conclusive, hope to see the vaccine…
Serbia gets shipment of AstraZeneca COVID-19 vaccine made in India
Another shipment of 150,000 vaccines is expected in 12 weeks time
China approves clinical trials for 16 indigenous COVID-19 vaccines
China has already given conditional approval to two inactivated COVID-19 vaccines made by state-owned developers -- Sinopharm and…
Serum Institute of India says prioritising domestic vaccine needs
Many low-and middle-income countries, ranging from Bangladesh to Brazil, are depending on SII’s AstraZeneca vaccine, branded…
UK to provide COVID-19 vaccine to all adults July-end
Britain now aims to give the first dose to all over-50s by April 15, the government said
World Bank striving for standard vaccine contracts, more data from vaccine producers
World Bank President David Malpass informed he expected the bank’s board to have approved $1.6 billion in vaccine funding for 12…
Bharat Biotech seeks approval for COVID-19 vaccine in over 40 countries
Pricing of COVAXIN for international markets will be based upon supply timelines, purchase commitments and procurement volumes,…
